Dr Amee George

Research Fellow
Manager - Target and Drug Discovery Platform
Room 3.356
 +61 2 612 53086


Devlin, JR, Hannan, KM, Hein, N, Cullinane, C, Kusnadi, E, Ng, PY, George, AJ, Shortt, J, Bywater, MJ, Poortinga, G, Sanij, E, Kang, J, Drygin, D, O'Brien, S, Johnstone, RW, McArthur, GA, Hannan RD and Pearson, RB (2016) Combination therapy targeting ribosome biogenesis and mRNA translation synergistically extends survival in MYC-driven lymphoma. Cancer Discovery 6(1):59-70

Quin, J, Chan, KT, Devlin, JR, Cameron, DP, Diesch, J, Cullinane, C, Ahern, J, Khot, A, Hein, N, George, AJ, Hannan, KM, Poortinga, G, Sheppard, KE, Khanna, KK, Johnstone, RW, Drygin, D, McArthur, GA, Pearson, RB, Sanij E and Hannan, RD (2016) Inhibition of RNA Polymerase transcription initiation activates non-canonical ATM/ATR signaling. Oncotarget. 2016 Jul 6. doi: 10.18632/oncotarget.10452. [Epub ahead of print]

Chan, KT, Paavolainen, L, Hannan, KM, George, AJ, Hannan, RD,  Simpson, KJ,  Horvath, P and Pearson, RB (2016) Whole-Genome RNAi screening and phenotypic classification analysis to identify regulators of oncogene-Induced senescence. Assay and Drug Development Technologies (in press)

Updated:  18 June 2018/Responsible Officer:  Director, JCSMR/Page Contact:  Web Manager